1,200 articles
Naomi Taylor
Naomi Taylor is an American immunologist and cancer researcher who leads a National Cancer Institute group studying CAR T cells and T cell metabolism for pediatric cancers.
Napoleone Ferrara
Napoleone Ferrara is a cell biologist and physician at UC San Diego, best known for isolating VEGF in 1989 and developing anti-VEGF therapies for cancer and blinding eye disease.
Nasser H. Hanna
Nasser H. Hanna is an American medical oncologist at the Indiana University School of Medicine in Indianapolis, known for lung cancer clinical research and founding End Lung Cancer Now.
Nathan Mantel
Nathan Mantel (1919–2002) was an American biostatistician who spent 1947 to 1974 at the National Cancer Institute and is best known for the Mantel–Haenszel procedure and the logrank test.
Nathanael S. Gray
Nathanael S. Gray is a chemical and systems biologist and the Krishnan-Shah Family Professor at Stanford University whose laboratory's cancer drug discovery informed ceritinib, osimertinib, and asciminib.
Neal G. Copeland
Neal G. Copeland is an American cancer geneticist at MD Anderson who co-developed recombineering and used the Sleeping Beauty transposon to find cancer genes in mice.
Nicholas A. Wright
Sir Nicholas A. Wright, born 1943, is a British histopathologist at Queen Mary University of London known for work on gastrointestinal stem cells and clonal evolution in tumors.
Nicholas C. Turner
Nicholas C. Turner is a British medical oncologist and Professor of Molecular Oncology at the Institute of Cancer Research, known for the SERENA-6 and INAVO120 breast cancer trials.
Nicholas Chiorazzi
Nicholas Chiorazzi is an American physician-scientist and immunologist known for chronic lymphocytic leukemia research; he heads the Karches Center for CLL Research at the Feinstein Institutes, Northwell Health.
Nicholas J. Dyson
Nicholas J. Dyson is a cancer biologist at Massachusetts General Hospital and Harvard Medical School known for identifying the p107 protein and showing that E2F-1 acts as a tumor suppressor.
Nicholas J. Vogelzang
Nicholas J. Vogelzang was an American medical oncologist specializing in genitourinary cancers and mesothelioma who led trials producing approvals of pemetrexed, abiraterone, and atezolizumab, and died in 2022.
Nicholas Lydon
Nicholas Lydon is a British biochemist who led the Ciba-Geigy tyrosine-kinase program that discovered imatinib (Gleevec), the first drug designed to inhibit a specific protein kinase.
Nicholas McGranahan
Nicholas McGranahan is a British computational biologist and Professor of Cancer Evolution at the UCL Cancer Institute, known for studying tumor heterogeneity and immune escape in lung cancer.
Nicholas P. Restifo
Nicholas P. Restifo is an American physician and immunologist known for developing cancer immunotherapies, leading anti-tumor T cell research at the National Cancer Institute for nearly three decades.
Nicola Aceto
Nicola Aceto (born 1982) is an Italian cancer biologist and professor of molecular oncology at ETH Zurich, known for discovering metastatic circulating tumor cell clusters.
Nikhil Wagle
Nikhil Wagle is an American physician-scientist in cancer genomics and precision oncology, a Harvard Medical School associate professor and breast medical oncologist at Dana-Farber Cancer Institute.
Nikolaus Schultz
Nikolaus Schultz is a computational oncologist at Memorial Sloan Kettering Cancer Center who co-leads cBioPortal and OncoKB, a precision oncology knowledge base partially recognized by the US FDA.
Nima Sharifi
Nima Sharifi is a prostate cancer medical oncologist and physician-scientist who identified the HSD3B1 mutation driving castration-resistant prostate cancer, leading the Desai Sethi Urology Institute since 2023.
Nina Bhardwaj
Nina Bhardwaj is an American physician-scientist in cancer immunotherapy at the Icahn School of Medicine at Mount Sinai, elected to the National Academy of Medicine in 2024.
Nir Hacohen
Nir Hacohen is an American immunologist who directs cancer immunology at Massachusetts General Hospital and is known for building single-cell maps of immune cells in tumors.
Nissim Hay
Nissim Hay is an Israeli-trained cancer biologist and Distinguished Professor at the University of Illinois Chicago, known for work on Akt signaling and tumor glucose metabolism.
Norman F. Boyd
Norman F. Boyd, also cited as Norman Boyd, is a physician and epidemiologist at the University of Toronto known for establishing mammographic density as a breast cancer risk factor.
Norman Wolmark
Norman Wolmark is an American surgical oncologist who succeeded Bernard Fisher as NSABP chairman in 1994 and leads NRG Oncology, designing landmark breast and colorectal cancer trials.
Norman Zamcheck
Norman Zamcheck was an American gastroenterologist and cancer researcher at Boston City Hospital and Harvard Medical School, known for his work on the CEA tumor marker.
Núria López-Bigas
Núria López-Bigas, also written Nuria Lopez-Bigas, is a Spanish computational biologist born in 1975 who studies cancer genomics, leads the Biomedical Genomics lab at IRB Barcelona, and teaches at Pompeu Fabra University.
Oliver Sartor
Oliver Sartor, also known as A. Oliver Sartor, is an American medical oncologist known for leading phase 3 trials of radium-223 and lutetium-177 prostate cancer therapies.
Oliver W. Press
Oliver W. Press was an American lymphoma physician-scientist at the Fred Hutchinson Cancer Research Center in Seattle who pioneered antibody and CAR T-cell treatments and died in 2017.
Olivia Pagani
Olivia Pagani is a Swiss-Italian medical oncologist specializing in breast cancer, best known for leading the TEXT and SOFT trials of ovarian suppression and the POSITIVE trial allowing pregnancy after breast cancer.
Olof Nyrén
Olof Nyrén is a Swedish physician and cancer epidemiologist, Professor Emeritus at Karolinska Institutet, known for NEJM studies linking gastroesophageal reflux to esophageal adenocarcinoma and a 1986 trial on non-ulcer dyspepsia.
Ömer Yılmaz
Ömer Yılmaz, also known as Omer H. Yilmaz, is a Turkish-American physician-scientist and gastrointestinal pathologist at MIT who studies how fasting and diet shape intestinal stem cells and cancer.